Changing the shape of GMP peptide manufacture

Alastair Hay, PhD, Account Manager – Peptides at Almac Sciences, explains how the company is advancing human health through innovation and investment in the field of individualised cancer vaccines.

View Resource

Please complete this form to view the Article

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies